Objective To characterize patterns of care at the end of life for children and young adults with life-threatening complex chronic conditions (LT-CCCs) and to compare them by LT-CCC type.
I mprovements in medical expertise and technology have led to a significant reduction in infant and childhood mortality over the past several decades and many more children are now living with life-threatening complex chronic conditions (LTCCCs), such as severe congenital anomalies, metabolic disorders, cystic fibrosis, neurodegenerative diseases, and the sequelae of extreme prematurity. [1] [2] [3] [4] Because of their multisystem diseases, technology dependence, and complex medication regimens, children and young adults with LT-CCCs often require a high level of medical care and technological support, even at the end of life (EOL). [5] [6] [7] Unsurprisingly, large population studies, including a recent cross-national review, demonstrate that the majority of children with LT-CCCs die in the hospital, 3, 7, 8 after prolonged periods of inpatient admission 9 and primarily in an intensive care unit (ICU) setting. 10, 11 In 2003, The Institute of Medicine's report, When Children Die: Improving Palliative and End-of-Life Care for Children and Their Families, called for more epidemiologic studies documenting the circumstances surrounding deaths during childhood. 12 Since that time, there have been multiple pediatric studies using administrative data and/or characterizing deaths in the inpatient setting. 1, 5, 7, 9, 11, [13] [14] [15] [16] Additionally, there have been numerous disease-specific studies in cancer [17] [18] [19] [20] [21] [22] and congenital heart disease.
this population 13 to enhance symptom management, optimize quality of life, help initiate discussions about advance care planning (ACP), aid in discerning patient and family preferences, and provide bereavement support to their families. 25, 26 Improving knowledge about the patterns of care at the EOL for children and young adults by LT-CCCs type may identify gaps, inform clinical practice, and ultimately improve the quality of EOL care for these children and their families. Therefore, the primary objective of this study was to characterize clinical characteristics and patterns of care at the EOL care for children and young adults with LT-CCCs by chronic condition type, focusing on conditions less well-described in the literature.
Methods
This prospective cross-sectional study is based on a survey of bereaved parents of children and young adults with LTCCCs. Parents were eligible for participation if (1) they were English speaking, (2) resided in North America with accurate contact information, (3) their child received care at Boston Children's Hospital (BCH) and died between January 2006 and December 2015, (4) at least 12 months had elapsed after their child's death, and (5) their child did not have cancer or congenital heart disease. To identify children and young adults with LT-CCCs, we used the definition of Feudtner et al of complex chronic conditions (CCC) defined as a child or young adult from 1 month of age with a medical condition reasonably expected to last at least 12 months (unless death intervenes) and to involve either several different organ systems or 1 system severely enough to require specialty pediatric care and some period of hospitalization in a tertiary care hospital. 9 In this article, we refer to CCCs as life threatening because all children with them in our cohort died. LT-CCCs were then systematically categorized into 5 primary types: central nervous system (CNS) progressive disorders, static encephalopathy, congenital and chromosomal, neuromuscular, and pulmonary disorders, by study investigators using a previously described classification system 27 to identify the predominant LT-CCC. Because these children often have multiple CCCs, in a small number of patients where it was difficult to discern the predominant LT-CCC from charting, 2 study investigators adjudicated to identify the primary LT-CCC type. Because many young adults with LT-CCCs continue to receive care at pediatric facilities until the middle of their fourth decade of life, we extended the age range of our cohort, including CCCrelated deaths from 1 month up to the 35th birthday. We excluded children with cancer and primary complex congenital heart disease because they likely represent distinct subgroups of LT-CCCs and recent assessments about patterns of care at the EOL exist in the literature. 20, 24, 28, 29 Bereaved parents were identified through the hospital bereavement committee database, which includes patients cared for at BCH who died in the hospital, at home, or elsewhere. Eligible parents were sent an introductory letter explaining the purpose of the study and a postage paid opt-out postcard. Three weeks later, a trained study investigator contacted the family by telephone to confirm their desire to participate and determine their preferred method of survey completion (paper or email). Ten days after distribution of the survey, a combined thank you-reminder card was sent to participating parents. Parents who did not return the survey after the reminder card were called twice-once after 2 weeks and again after 4 weeks. Parents who declined participation were not further approached. This study was approved by the Institutional Review Board at BCH.
The survey Caring for Children with Complex Chronic Conditions (5Cs) was adapted from a previously validated instrument, Survey about Caring for Children with Cancer, which measured parental perceptions of EOL care for children with cancer 17 and multiple prior studies have used the Survey about Caring for Children with Cancer or an adaptation of this survey. 24, 28, 29 Relevant items were selected and new items related to communication around ACP for children with LT-CCCs were developed de novo on the basis of literature review and the opinions of an advisory board composed of interdisciplinary clinicians and parents of children with LT-CCCs from the Parent Advisory Council at BCH. Cognitive validity, wording, response burden, and willingness to participate were then assessed in a sample (n = 11) of bereaved parents of children with LT-CCCs. The final survey instrument (5Cs), a semistructured 183-item questionnaire, includes parental perspectives on (1) information about the child and their LT-CCC, (2) communication around prognosis after their child's diagnosis or recognition of serious illness, (3) communication and shared decision making around ACP, (4) patient and family experience at the EOL and time of death, (5) bereavement and family support, (6) family characteristics, and (7) parental experience with research participation in this survey. The survey questions and specific survey domains included in this analysis from sections 1, 4, and 6 are detailed in (Table I ; available at www.jpeds.com).
Trained research assistants abstracted the medical records of all eligible children to confirm the child's primary diagnosis and date of death, and to determine the child's age, race, sex, insurance type, do not resuscitate (DNR) order status, technology dependence (chronic noninvasive ventilation, tracheostomy and mechanical ventilation, enteral feeding tube, and/or ventriculoperitoneal shunt), and number of hospital admissions, ICU admissions, and hospital duration of stay in the last year of life. Mode of death was classified by study personnel based on chart review and describes the categorization of death along the dimensions of intervention in the immediate EOL period and/or terminal admission as previously described. 30 "Died while receiving comfort care" describes those children who died because a decision was made not to initiate any new, life-sustaining interventions during the immediate EOL period or terminal admission. "Died receiving mechanical ventilation and/or cardiopulmonary resuscitation (CPR)" refers to those patients who died while receiving mechanical or noninvasive ventilation or despite active CPR. "Died after withdrawal or withholding of life-sustaining therapies" describes patients who had any life-sustaining therapies in place within the immediate EOL period or terminal admission that, once withdrawn, resulted in the patient's death.
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Duration of illness, any involvement of palliative care and DNR orders at any time during their child's illness, the ability to plan their child's location of death, actual location of death, and data regarding intensive life-sustaining measures in the last 2 days of life defined as mechanical ventilation, CPR, and/or extracorporeal membrane oxygenation, was obtained from the survey instrument (5Cs). The 2-day window before death was selected to identify intensive therapies provided to patients with LT-CCCs at the very EOL. Parent demographics were obtained from the survey for those who completed it, including age, sex, race, number of children, time since child's death, primary language, income, education level, marital status, and religion. The source of all data elements used in this analysis are detailed in Table I .
Analyses were conducted using Stata statistical software (StataCorp, 2015, College Station, Texas). Pilot sample responses were not included in the final survey analyses. Patient and parent demographics, clinical characteristics, and resource use were described using frequencies and medians with IQRs where appropriate. Primary outcomes assessing patterns of care at the EOL included mode of death, location of death, parental ability to plan their child's location of death, intensive life-sustaining therapies in last 2 days of life, DNR orders, and the receipt of palliative care. To investigate the association between LT-CCC type and the outcomes of interest, analyses were conducted using the c 2 and Fisher exact tests. Multivariable logistic regression was then used to assess the associations between primary outcomes and LT-CCC type with CNS progressive as the reference group. The CNS progressive group was chosen as the reference group because they tend to have a more predictable clinical course than other LT-CCC types, with a gradual decline over a long period of time. Potential confounders (sex, race, technology dependence, distance of the child's home from the hospital, and insurance) were chosen a priori as well as significant predictors (P < .1; age) for model inclusion. Factors that were found to be nonsignificant or were not appreciable confounders of associations (insurance and distance of the child's home to the hospital) were removed to obtain the final model with results reported as AORs with 95% CIs).
Results
Of the 1597 patients screened, 211 were eligible for participation. Of those 211 invited to participate, 61 parents (29%) declined, 36 parents (17%) did not respond, and 114 parents completed the survey, yielding a 54% participation rate ( Figure; available at www.jpeds.com). The demographics of parents who participated in the survey are detailed in Table II . Parents were primarily female (81.9%) with a median age of 47.5 years (IQR, 40-57). A majority of parents were white (82.5%), married (80.0%), and Christian (62.1%), with at least some college education (83.8%). Parents completed the survey a median of 3.9 years after the death of their child.
Demographics and clinical characteristics of deceased children and young adults with LT-CCCs are detailed in Table III . Those with LT-CCCs were primarily white (77.2%), with a median age at death of 10.5 years, ranging from 8 months to 35 years of age. Children with congenital and chromosomal disorders (38.6%) such as trisomy 21 or congenital diaphragmatic hernia comprised the largest subset with LT-CCCs, followed by those with CNS progressive disorders (37.6%) such as a mucopolysaccharidoses or Retts disease. Approximately 17% had static encephalopathy and the remaining had either neuromuscular disease (11.4%) such as Duchenne muscular dystrophy or pulmonary disorders (9.7%), primarily cystic fibrosis. Seventy-five percent of patients in our cohort had Children of nonrespondents (n = 36) were less likely to be of white race (56 % vs 77 %; P = .01) and to have palliative care involvement (61% vs 79%; P = .03). There were no differences between children whose parents participated in the study and those of nonrespondents with respect to age, sex, insurance type, technology dependence, time since death, mode of death, the presence of DNR orders, or primary LT-CCC groups.
Patterns of care at the EOL for children and young adults with LT-CCCs are displayed in Table IV . The majority of patients died in the hospital (62.7%) with more than one-half (53.3%) dying in the ICU. Those with CNS progressive disorders were more likely to die at home, and those with static encephalopathy, congenital and chromosomal disorders, neuromuscular disease, and pulmonary disorders were more likely to die in the hospital. Of the patients, 46.5% died after withdrawal or withholding of life-sustaining therapies, 17.5% died during active resuscitation with new mechanical ventilation or CPR, and 36% died while receiving comfort care only. There was wide variation across the 5 primary LT-CCC types, with no patients with pulmonary disorders dying with comfort care only compared with 66.7% of those with CNS progressive disorders. One-half of the bereaved parents surveyed reported that they were able to plan their child's location of death, with wide variation between LT-CCCs types. For example, parents of children with CNS progressive disorders reported being able to plan their child's location of death 87.0% of the time and those with pulmonary disorders (30%) and congenital and chromosomal disorders (40.5%) were able to plan their child's location of death less than one-half of the time. A little more than one-quarter of patients (27.9%) received intensive life-sustaining therapies, such as mechanical ventilation or CPR, in the last 2 days of life, and this finding was more prominent in patients with pulmonary disorders (45.5%), congenital and chromosomal disorders (38.1%), and static encephalopathy (33.3%). There were no differences between LT-CCCs groups regarding the presence of DNR orders (62.5%). A majority of patients in our cohort had a palliative care consult (79.3%). Receipt of palliative care varied across groups, with patients having CNS progressive disorders reporting the highest rates of palliative care involvement (96.0%) compared with those with static encephalopathy and pulmonary disorders (62.5 and 70.0%, respectively).
In multivariable models (Table V) Those with neuromuscular disorders were significantly less likely to have DNR orders than CNS progressive disorders (AOR, 0.14; 95% CI, 0.03-0.79), but there were no other differences between the 2 populations with respect to location Values are n (%).
Associations were assessed between life-threatening CCC types using c 2 and Fisher exact tests.
of death, mode of death, receipt of intensive life-sustaining measures in the last 2 days of life, palliative care, or the parental ability to plan their child's location of death. Last, children with pulmonary disorders were significantly more likely to die after withdrawal or withholding of lifesustaining interventions than those CNS progressive disorders (AOR, 23.16; 95% CI, 2.42-221.35), 12-fold as likely to receive life-sustaining therapies in last 2 days of life (AOR, 11.92; 95% CI, 1.11-127.64), and significantly less likely to receive a palliative care consult (AOR, 0.07; 95% CI, 0.01-0.90). Parents of those with pulmonary disorders were also significantly less likely to have the ability to plan their child's location of death (AOR, 0.17; 95% CI, 0.03-0.99) than those with CNS progressive disorders with a 6-fold likelihood (AOR, 6.82; 95% CI, 1.12-41.47) of dying in the ICU.
Discussion
It has been reported that children and young adults with LTCCCs often receive their EOL care in the inpatient hospital setting with intensive life-sustaining medical therapies common before death, which generally occurs after withdrawal or withholding of those life-sustaining therapies. 1, [30] [31] [32] This study supports these findings for a majority of children and young adults with LT-CCCs, but provides new insight into important differences in patterns of EOL care across LT-CCC types. Specifically, for patients cared for at our large quaternary care medical center, location of death, mode of death, parental ability to plan their child's location of death, the presence of intensive life-sustaining therapies in the last 2 days of life, DNR orders, and the receipt of palliative care all differed significantly by LT-CCCs type. In our cohort, more than one-half of children and young adults with pulmonary disorders, static encephalopathy, and congenital and chromosomal disorders died in the ICU compared with those with CNS progressive or neuromuscular disorders, who were more likely to die at home. These patients were also significantly more likely to die after withdrawal or withholding of life-sustaining therapies or during active resuscitation when compared with patients with CNS progressive disorders, who were more likely to die receiving comfort care.
Although the overall receipt of palliative care for children and young adults with LT-CCCs was high in this study (79.3%) compared with published literature describing deaths in the general pediatric population, 16, 25 we noted important differences between LT-CCCs groups with respect to the receipt of palliative care. Importantly, children and young adults with pulmonary disorders and static encephalopathy were significantly less likely to receive palliative care at any time during their illness, compared with those with CNS progressive and neuromuscular disorders. In addition, and perhaps related to this decreased incidence of palliative care involvement, parents of children with pulmonary disorders and congenital and chromosomal disorders were more likely to be unable to plan their child's location of death, which has been identified as a superior proxy for high-quality EOL care than actual location of death. 18 Children and young adults with CCCs have lifelong, lifethreatening conditions and for many, early death is an inevitable outcome of their disease process; however, differences exist with respect to their illness trajectories that may influence the distinct patterns of care at EOL observed in this study. Published data suggest that pediatric patients who die typically experience 1 of 4 different trajectories of illness: sudden death (eg, trauma), a steady inexorable decline (eg, cancer, neurodegenerative disorders, and neuromuscular disease), fluctuating decline (eg, progressive diseases with intermittent crises such as cystic fibrosis), and constant medical fragility (eg, static encephalopathy predisposing to crises owing to infections). 33 It is plausible that these distinct illness The life-threatening CCC reference group is CNS progressive disorders. Binary outcomes were assessed using logistic regression and all analyses were adjusted for age at death, sex, race, technology dependence.
THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 193 trajectories and specifically the greater prognostic uncertainty commonly observed in those with fluctuating decline and constant medical fragility, result in different barriers to palliative care involvement, ACP, and ultimately observed EOL care patterns. For example, children and young adults with static encephalopathy often have medical fragility resulting in unpredictable life-threatening crises interspersed with periods of stability, making it difficult to determine the ideal time for palliative care involvement and ACP 34 for parents and providers alike. This phenomenon has been described in the adult patients with chronic heart failure, who, despite similar disease burden, receive less palliative care consultation than those with cancer owing to the cyclic course of disease, which makes determination of the appropriate timing of palliative care challenging. 35 Many patients with cystic fibrosis, in contrast, have known that they have a life-limiting disease for the majority of their lives and barriers to palliative care involvement and ACP in this case may include the hope offered by transplantation and new therapies. 36 Despite differences in the trajectory of LT-CCCs, all of these patients and their families could benefit from being offered earlier involvement of palliative care services to address symptom management, optimize quality of life, facilitate ACP discussions, ensure that medical care occurs in concordance with patient and family goals and values, and provide bereavement support. 25, 37, 38 The literature supports the benefits of palliative care with children and young adults who receive palliative care services undergoing fewer procedures, having improved documentation of pain management, shorter duration of inpatient stay, and lower daily charges during their terminal hospitalization. 16, 22, 25, 37 The impact of palliative care is mirrored in the adult population where studies demonstrate greater satisfaction with patients' care experience, providers' communication, and lower total health care costs at the EOL [39] [40] [41] in patients receiving palliative care. These benefits also extend to chronic heart failure, where, despite prognostic uncertainty, a recent, randomized control trial of a palliative care intervention demonstrated consistently greater benefits in quality of life, anxiety, depression, and spiritual well-being in the palliative care arm compared with the usual care arm. 35 Unfortunately, despite this compelling evidence, studies still show that more than one-half of parents of children with lifethreatening illness indicated that the opportunity to participate in ACP and to plan their child's EOL care was a poorly met need. 27 As a result, the American Academy of Pediatrics endorsed the concurrent use of palliative care and curative care for children with a life-threatening illness. 42 This statement was reaffirmed and expanded in 2013 by the American Academy of Pediatrics, which now strongly recommends the integration of palliative care into the medical home of children with life-threatening conditions from the moment of diagnosis and throughout the illness course. 43 Our analysis was nevertheless limited in several ways. First, the number of children in certain LT-CCCs subcategories was small, warranting some caution in interpretation of the percentages. In addition, the study relies, in part, on recall from bereaved parents which, may not accurately reflect the actual experience of their child; however, this is an accepted standard in the pediatric literature and for this population. 17, 24, 29, 43, 44 This study also describes the experience at a single, large, quaternary care children's hospital with a well-established palliative care program, which may explain the high rate of palliative care involvement among our patients and influence generalizability, although a majority of children with LTCCCs in this country are cared for at large centers. Of note, the palliative care program at BCH has been in place since 1997 and is composed of an interdisciplinary team that provides services at the hospital, outpatient setting, and in the community. Additionally, because we did not collect information about timing or frequency of palliative care involvement, we do not know the extent to which these factors influenced observed patterns of care at the EOL and future studies should include more detail about palliative care involvement. Finally, selection bias may limit our findings, because it is possible that parent participants may report systematically different EOL experiences for their children than nonparticipants. Moreover, the lack of significant representation of participants with racial, ethnic, sex, and socioeconomic diversity may also influence generalizability. There are several small studies that suggest there may be differences between perceptions of care at the EOL 45 and preferred place of death 46 by parent sex, as well as racial and cultural factors that influence the motivation to speak about ACP and death in general 47 ; thus, the replication of our findings in a more diverse population is warranted. However, messages about tailoring EOL care to individual children and families with LT-CCCs and ensuring access to palliative care for all families that desire it should be considered as important among populations who have not been well-studied.
Despite these limitations, the design of this study allowed us to survey a large number of bereaved parents of children and young adults with LT-CCCs, characterize patterns of care at the EOL for this population, and identify vulnerable populations with variable receipt of palliative care. Although this study confirms that most children with LT-CCCs spend their last days in an acute care setting, the literature suggests that many parents prefer their child die at home 48 with preferences dependent on experiences of care, and in-hospital death preferred if community resources to care for the child at home are limited. 16, 25, 34 Moreover, recent data suggest that the ability to plan a child's location of death, as opposed to the actual location of death, may be more important to parents of children with life-threatening illness, 18 as is a focus on factors that positively influence the experience of EOL care, regardless of location. 49 This study also demonstrates that intensive lifesustaining measures continue to be a part of care at the EOL for many children with LT-CCCs and, at present, it is unclear whether this is concordant with a family's preferences.
Although there is no correct choice for the style and location of EOL care for all children and young adults with LTCCCs, this study has identified differences in care between LT-CCC types that may profoundly impact the EOL experiences for these patients and their families. Future studies are needed to quantify the added value of palliative care involvement in these populations, to determine the proportion 
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of in-hospital deaths that are consistent with well-informed family goals and values, and to examine whether children and young adults with LT-CCCs who receive high-intensity EOL care experience high suffering or poor quality of life. This study provides much-needed information about the nature of care that children and young adults with LT-CCCs receive before their deaths. Additionally, the study identifies potential opportunities to improve the quality of EOL care for these children by tailoring EOL care to individual patients and families, and ensuring access to palliative care for all patients with LTCCCs who desire it. ■ 
